G. Steven Burrill

An introduction to Burrill Venture Capital

Flash required to view this video. Download the latest version here

 G. Steven Burrill 

News

Biotech takes a beating in market meltdown October 01, 2008 | Press Release

Biotech outperforms market in May June 02, 2008 | Press Release

Biotech Treads Water in April May 01, 2008 | Press Release

  See all News
Sign up to receive email notifications about our upcoming events and news.


Submit a Business Plan

Do great things with us.Click here 
Venture Capital

 


Phytomedics uses a broad and innovative proprietary technology platform to discover, develop and manufacture novel, multi-component and multi-functional botanical therapeutics such as nutraceuticals and botanical drugs, as well as novel recombinant proteins. Through this proprietary technology platform, the Company has produced a pipeline of nutraceutical and pharmaceutical lead compounds, several of which are in clinical development.

For more information, please visit

Website: http://www.phytomedics.com